RxDoctor Payments DataLook up a doctor →

William McGarvey, MD

Foot and Ankle Surgery · Katy, TXNPI 1679544308

Payments from drug & device makers

$3,507,723in general payments, 2019–2025

Across 536 payments — averaging $6544.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3.4M
  • Extremity Medical$53K
  • Treace Medical Concepts, Inc.$4K
  • Medinc Of Texas$2K
  • Alafair Biosciences, Inc.$694
  • Medshape, Inc.$510
  • plus $4K from 23 others
$13,647in research payments, 2019–2025

Across 40 payments — averaging $341.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$14K

What the payments were for

  • Royalty or licence$3,035,02387%
  • Consulting fees$387,34911%
  • Speaking & faculty fees$22,7591%
  • Travel & lodging$44,9371%
  • Food & beverage$15,5390%
  • Education$1,2850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,507,723 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$140,355
Medicare patients
250
Services billed
1,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen157$2,088
Cephalexin131$970
Pregabalin12$832
Gabapentin33$354
Methylprednisolone44$215
Promethazine Hcl40$210
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$184
Tramadol Hcl25$98
Meloxicam27$80
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$46

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →